Fig. 3From: A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinomaKaplan-Meier analyses of LUAD patients with age, gender, and smoking behavior, including a ≥ 65 years, b < 65 years, c male, d female, e smoking, and f nonsmokingBack to article page